SOLV logo

SOLVENTUM CORP

SOLVNYSE
πŸ† #669 by market capEarnings Nov 4US Equity
$89.38β–Ό $0.18 (βˆ’0.20%)
After hours Β· at close
πŸ””
Track SOLV
Get earnings, price moves & breaking news on Telegram
Track
24hβ–Ό 0.2%
7dβ–² 0.7%
14dβ–Ό 0.8%
30dβ–Ό 1.9%
ytdβ–² 12.8%
1yβ–² 23.8%
🏦Market Cap
$15.48B
Mid Cap
πŸ“ˆRevenue Growth (YoY)
-0.9%
Declining
πŸ“ŠGross Margin
54.8%
Healthy
πŸ’΅FCF Margin
2.1%
Thin
βš–οΈP/S Ratio
1.8x
Cheap
Otter Score
80
Good

Trading Snapshot

Day Range
$87.99 – $91.14
52-Week Range
$62.38 – $94.16
Volume
$1.66B
Avg Volume
$2.14B
Shares Outstanding
173.2M
Next Earnings
Nov 15, 2026

Fundamentals Snapshot

Annual Revenue
$8.32B
Last Q Revenue
$2.21B
P/E Ratio
10.6
P/S Ratio
1.8x
EPS (TTM)
$8.19
Dividend Yield
β€”
Dilution (1yr)
+0.5%

Why Investors Own SOLV

  • βœ“High-growth profile β€” revenue up +5.5% YoY with expanding US Equity exposure.
  • βœ“Healthy economics β€” 45% gross margin and 21% free-cash-flow margin.
  • βœ“New products and segments could unlock additional revenue streams.
⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

SOLV logo

SOLVENTUM CORP

SOLV
Financial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$8.3Bβ–² +0.9% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
53.5%β–Ό βˆ’3.9% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
$2.2Bβ–² +110.5% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
βˆ’$10Mβ–Ό βˆ’101.2% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
175.3Mβ–² +0.5% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
βˆ’$4.2Bβ–² +$3.1B YoY
StockOtter Β· stockotter.space

About SOLVENTUM CORP

Solventum Corporation, established in 2023 and headquartered in Saint Paul, Minnesota, operates as a healthcare entity dedicated to pioneering, producing, and commercializing diverse solutions that address critical needs for both customers and patients. The company's business activities are organized into four principal segments. The Medsurg division furnishes various products and services, including sophisticated wound care items, intravenous (I.V.) site management tools, sterilization assurance systems, temperature regulation devices, surgical instruments, stethoscopes, and medical electrodes. Its Dental Solutions segment provides a comprehensive range of dental and orthodontic offerings, such as brackets, clear aligners, restorative filling materials, and bonding agents. The Health Information Systems division concentrates on advanced software platforms, covering functionalities like computer-assisted physician documentation, direct billing and coding automation, classification frameworks, voice recognition capabilities, and data visualization tools. Finally, the Purification and Filtration segment supplies an array of purification and filtration technologies, including various filters, purifiers, cartridges, and specialized membranes.

🦦

Otter Score Breakdown

How it's scoredFive components, each rated 1–5β˜… and equally weighted (20%), averaged to a 0–100 score:πŸ’Ž Quality β€” gross marginπŸš€ Growth β€” revenue YoYβš–οΈ Valuation β€” P/S ratio⚑ Momentum β€” 30-day price changeπŸ’§ Dilution β€” 1-yr share issuance (buybacks score higher)
πŸ’ŽQualityβ˜…β˜…β˜…β˜…β˜…
πŸš€Growthβ˜…β˜…β˜…β˜…β˜…
βš–οΈValuationβ˜…β˜…β˜…β˜…β˜…
⚑Momentumβ˜…β˜…β˜…β˜…β˜…
πŸ’§Dilutionβ˜…β˜…β˜…β˜…β˜…
Overall Score
Good
80/100

Analyst Ratings

β“˜
Consensus
Buy
22 analysts
Strong Buy6
Buy7
Hold8
Sell1
Strong Sell0
Ratings as of Sep 2026

Latest News & Updates